The estimated Net Worth of Thomas Graney is at least $6.26 Milion dollars as of 1 October 2018. Thomas Graney owns over 1,076 units of Vertex Pharmaceuticals stock worth over $5,901,018 and over the last 10 years Thomas sold VRTX stock worth over $360,968.
Thomas has made over 4 trades of the Vertex Pharmaceuticals stock since 2016, according to the Form 4 filled with the SEC. Most recently Thomas sold 1,076 units of VRTX stock worth $207,926 on 1 October 2018.
The largest trade Thomas's ever made was selling 1,874 units of Vertex Pharmaceuticals stock on 22 February 2017 worth over $31,746. On average, Thomas trades about 429 units every 95 days since 2014. As of 1 October 2018 Thomas still owns at least 12,430 units of Vertex Pharmaceuticals stock.
You can see the complete history of Thomas Graney stock trades at the bottom of the page.
Thomas's mailing address filed with the SEC is C/O IRONWOOD PHARMACEUTICALS, INC., 301 BINNEY STREET, CAMBRIDGE, MA, 02142.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden oraz Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: